Tran D, Sinclair R D, Schwarer A P, Chow C W
Department of Dermatology, Alfred Hospital, Prahran, Australia.
Australas J Dermatol. 2000 May;41(2):106-8. doi: 10.1046/j.1440-0960.2000.00405.x.
Alopecia can be a psychologically daunting prospect for people requiring cancer chemotherapy. Fortunately, most patients experience only temporary hair loss. We report the case of a 23-year-old woman with chronic myeloid leukaemia who developed permanent, near-total alopecia of her scalp, eyebrows, eyelashes, axillary and public hair following busulphan and cyclophosphamide chemotherapy which was used as conditioning prior to allogeneic bone marrow transplantation. The histology from a scalp biopsy revealed hair follicle destruction. Topical minoxidil failed to induce significant re-growth.
对于需要进行癌症化疗的患者而言,脱发可能是一个令人心理畏惧的情况。幸运的是,大多数患者仅经历暂时性脱发。我们报告了一名23岁慢性髓性白血病女性的病例,她在接受白消安和环磷酰胺化疗(作为异基因骨髓移植前的预处理)后,头皮、眉毛、睫毛、腋毛和阴毛出现了永久性、几乎完全脱发。头皮活检的组织学检查显示毛囊遭到破坏。局部外用米诺地尔未能显著促进头发生长。